UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
AngioDynamics
ANGO
$649M
| $717K | ﹤0.01% |
30,628
| – | – |
|
2177
BioXcel Therapeutics
BTAI
$27.8M
| $716K | ﹤0.01% |
1,038
+225
| +28% | +$181K |
|
|
WOW
2178
DELISTED
WideOpenWest
WOW
| $716K | ﹤0.01% |
52,653
+10,654
| +25% | +$140K |
|
|
AAN
2179
DELISTED
The Aaron's Company Inc
AAN
| $714K | ﹤0.01% |
27,799
+800
| +3% | +$17.5K |
|
2180
Tompkins Financial
TMP
$1.42B
| $711K | ﹤0.01% |
8,600
| – | – |
|
2181
C3.ai
AI
$1.59B
| $708K | ﹤0.01% |
10,748
-19,252
| -64% | -$2.24M |
|
2182
United Fire Group
UFCS
$1.4B
| $707K | ﹤0.01% |
20,328
| – | – |
|
|
PETQ
2183
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $707K | ﹤0.01% |
20,060
+522
| +3% | +$18.5K |
|
2184
Zumiez
ZUMZ
$339M
| $707K | ﹤0.01% |
16,476
-2,517
| -13% | -$112K |
|
|
SILV
2185
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $706K | ﹤0.01% |
87,200
+18,800
| +27% | +$172K |
|
2186
Green Plains
GPRE
$1.03B
| $704K | ﹤0.01% |
26,001
+15,991
| +160% | +$366K |
|
|
SPTN
2187
DELISTED
SpartanNash
SPTN
| $703K | ﹤0.01% |
35,794
| – | – |
|
2188
National Healthcare
NHC
$3.38B
| $702K | ﹤0.01% |
9,015
| – | – |
|
2189
Andersons Inc
ANDE
$2.22B
| $702K | ﹤0.01% |
25,643
-4,666
| -15% | -$124K |
|
2190
MBIA
MBI
$260M
| $701K | ﹤0.01% |
72,893
-13,349
| -15% | -$103K |
|
2191
Globalstar
GSAT
$10.8B
| $699K | ﹤0.01% |
34,497
+1,415
| +4% | +$29.6K |
|
2192
Immunovant
IMVT
$8.25B
| $698K | ﹤0.01% |
43,547
-1,094
| -2% | -$28.8K |
|
|
EPZM
2193
DELISTED
Epizyme, Inc
EPZM
| $698K | ﹤0.01% |
80,119
+8,902
| +12% | +$92.1K |
|
2194
Mitek Systems
MITK
$834M
| $697K | ﹤0.01% |
47,823
+6,323
| +15% | +$101K |
|
2195
Tactile Systems Technology
TCMD
$665M
| $695K | ﹤0.01% |
12,763
-4,017
| -24% | -$215K |
|
2196
Gogo Inc
GOGO
$492M
| $695K | ﹤0.01% |
71,980
-14,031
| -16% | -$167K |
|
2197
Utz Brands
UTZ
$1.25B
| $694K | ﹤0.01% |
+28,000
| New | +$679K |
|
2198
Lands' End
LE
$403M
| $693K | ﹤0.01% |
27,930
| – | – |
|
2199
Telecom Argentina
TEO
$5.96B
| $692K | ﹤0.01% |
125,303
-1,982
| -2% | -$12.2K |
|
|
TRTX
2200
TPG RE Finance Trust
TRTX
$618M
| $691K | ﹤0.01% |
61,659
| – | – |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.